Conflict of interest: Nothing to report.
Polymorphisms of drug-metabolizing genes and risk of non-Hodgkin lymphoma†
Version of Record online: 8 OCT 2009
Copyright © 2009 Wiley-Liss, Inc.
American Journal of Hematology
Volume 84, Issue 12, pages 821–825, December 2009
How to Cite
Kim, H. N., Kim, N. Y., Yu, L., Kim, Y.-K., Lee, I.-K., Yang, D.-H., Lee, J.-J., Shin, M.-H., Park, K.-S., Choi, J.-S. and Kim, H.-J. (2009), Polymorphisms of drug-metabolizing genes and risk of non-Hodgkin lymphoma. Am. J. Hematol., 84: 821–825. doi: 10.1002/ajh.21556
- Issue online: 23 NOV 2009
- Version of Record online: 8 OCT 2009
- Accepted manuscript online: 8 OCT 2009 12:00AM EST
- Manuscript Accepted: 30 SEP 2009
- Manuscript Revised: 24 SEP 2009
- Manuscript Received: 29 JUL 2009
- Korea Health 21 R&D Project, Ministry of Health and Welfare, Republic of Korea. Grant Number: A01-0385-A70604-07M7-00000A
- 1Non-Hodgkin lymphoma. In: SchottenfeldD,FraumeniJFJr, eds. Cancer epidemiology and prevention. Oxford, United Kingdom: Oxford University Press, 2006: 898–918., et al.
- 2Short-term carcinogenicity testing of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) and 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) in E(mu)-pim-1 transgenic mice. Carcinogenesis 1996; 17: 2221–2227., et al.
- 3National Toxicology program. Bioassay of 2,4-diaminotoluene for possible carcinogenicity. Natl Cancer Inst Carcinog Tech Rep Ser 1979; 162: 1–139.
- 4Induction of lymphoma in CDF1 mice by the food mutagen, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. Jpn J Cancer Res 1989; 80: 1176–1178., et al.
- 5Induction of intestinal tumors and lymphomas in C57BL/6N mice by a food-borne carcinogen, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. Jpn J Cancer Res 2002; 93: 478–483.et al.
- 6Alcohol consumption and risk of non-Hodgkin lymphoma: A pooled analysis. Lancet Oncol 2005; 6: 469–476., et al.
- 7Tobacco and alcohol consumption and risk of lymphoma: Results of a population-based case-control study in Germany. Int J Cancer 2006; 118: 422–430., et al.
- 8Alcohol, smoking, and body size in relation to incident Hodgkin's and non-Hodgkin's lymphoma risk. Am J Epidemiol 2007; 166: 697–708., et al.
- 9Cigarette smoking, alcohol drinking, and risk of lymphoid neoplasms: Results of a French case-control study. Cancer Causes Control 2008; 19: 1147–1160., et al.
- 10Tobacco smoking, alcohol drinking and non-Hodgkin's lymphoma: A European multicenter case-control study (Epilymph). Int J Cancer 2006; 119: 901–908., et al.
- 11Cigarette smoking and risk of non-Hodgkin lymphoma: A pooled analysis from the International Lymphoma Epidemiology Consortium (interlymph). Cancer Epidemiol Biomarkers Prev 2005; 14: 925–933., et al.
- 12Diet and risk of non-Hodgkin lymphoma in older women. JAMA 1996; 275: 1315–1321., et al.
- 13Tobacco, alcohol, diet and risk of non-Hodgkin's lymphoma: A case-control study in Uruguay. Leuk Res 1998; 22: 445–452., et al.
- 14Dietary factors and risk of non-Hodgkin lymphoma by histologic subtype: A case-control analysis. Cancer Epidemiol Biomarkers Prev 2004; 13: 1665–1676., et al.
- 15Pharmacogenetics of the major polymorphic metabolizing enzymes. Fundam Clin Pharmacol 2003; 17: 27–41..
- 16Functional significance of different human CYP1A1 genotypes. Carcinogenesis 1994; 15: 2961–2963., et al.
- 17NAD(P)H: Quinone oxidoreductase (NQO1) polymorphism, exposure to benzene, and predisposition to disease: A HuGE review. Genet Med 2002; 4: 62–70., et al.
- 18Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. Biochem J 1994; 300 (Part 1): 271–276., et al.
- 19Activity of four allelic forms of glutathione S-transferase hGSTP1-1 for diol epoxides of polycyclic aromatic hydrocarbons. Biochem Biophys Res Commun 1997; 238: 397–402., et al.
- 20Molecular cloning, characterization, and expression in Escherichia coli of full-length cDNAs of three human glutathione S-transferase Pi gene variants. Evidence for differential catalytic activity of the encoded proteins. J Biol Chem 1997; 272: 10004–10012., et al.
- 21Naturally occurring human glutathione S-transferase GSTP1-1 isoforms with isoleucine and valine in position 104 differ in enzymic properties. Eur J Biochem 1994; 224: 893–899., et al.
- 22Metabolic gene variants and risk of non-Hodgkin's lymphoma. Cancer Epidemiol Biomarkers Prev 2006; 15: 1647–1653., et al.
- 23Genetic polymorphisms of biotransformation enzymes in patients with Hodgkin's and non-Hodgkin's lymphomas. Int Arch Occup Environ Health, 2002; 75 ( Suppl): S86–S92., et al.
- 24Genetic polymorphisms of biotransformation enzymes in patients with Hodgkin's and non-Hodgkin's lymphomas. Hum Mol Genet 2001; 10: 1265–1273., et al.
- 25Genetic polymorphisms in glutathione S-transferases and cytochrome P450s, tobacco smoking, and risk of non-Hodgkin lymphoma. Am J Hematol 2009; 279–282., et al.
- 26Polymorphisms of drug-metabolizing enzymes CYP1A1, GSTT and GSTP contribute to the development of diffuse large B-cell lymphoma risk in the Saudi Arabian population. Leuk Lymphoma 2008; 49: 122–129., et al.
- 27Association between xenobiotic gene polymorphisms and non-Hodgkin's lymphoma risk. Br J Haematol 2002; 118: 477–481., et al.
- 28World Health Organization Classification of Tumours Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC Press: IARC Press; 2001., et al.
- 29Association between folate-metabolizing pathway polymorphism and non-Hodgkin lymphoma. Br J Haematol 2008; 140: 287–294., et al.
- 30Polymorphisms in genes encoding drug metabolizing enzymes and their influence on the outcome of children with neuroblastoma. Pharmacogenet Genomics 2007; 17: 709–717., et al.
- 31Association of NAT and GST polymorphisms with non-Hodgkin's lymphoma: A population-based case-control study. Br J Haematol 2005; 128: 610–615., et al.
- 32Differences in the catalytic efficiencies of allelic variants of glutathione transferase P1-1 towards carcinogenic diol epoxides of polycyclic aromatic hydrocarbons. Carcinogenesis 1998; 19: 433–436., et al.
- 33Glutathione S-transferase P1 Ile105Val polymorphism, cigarette smoking and prostate cancer. Cancer Detect Prev 2004; 28: 368–374., et al.
- 34Xenobiotic metabolizing gene variants, dietary heterocyclic amine intake, and risk of prostate cancer. Cancer Res 2009; 69: 1877–1884., et al.
- 35Meat intake, heterocyclic amine exposure, and metabolizing enzyme polymorphisms in relation to colorectal polyp risk. Cancer Epidemiol Biomarkers Prev 2008; 17: 320–329., et al.
- 36Modification by N-acetyltransferase 1 genotype on the association between dietary heterocyclic amines and colon cancer in a multiethnic study. Mutat Res 2008; 638: 162–174., et al.
- 37Interaction of the cytochrome P4501A2, SULT1A1 and NAT gene polymorphisms with smoking and dietary mutagen intake in modification of the risk of pancreatic cancer. Carcinogenesis 2008; 29: 1184–1191., et al.